Fact CheckerSign in

NCT06599684CompletedPhase 2

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)

Source: ClinicalTrials.gov · Last updated 2 Oct 2026

Brief summary (registry, in English)

Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during a 12-week dosing period in subjects with non-center involved DME (NCIDME) associated with NPDR \[Part 1\] and during an 8-week dosing period in subjects with center-involved DME (CIDME) associated with NPDR \[Part 2\].

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
19 (actual)
First submitted
13 Sept 2024
Start date
7 Sept 2024
Primary completion date
30 Sept 2025
Lead sponsor
Invirsa, Inc.
NCT number
NCT06599684

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 19
  • From 7 Sept 2024 to the primary completion date, 30 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior laser treatment for DR in the study eye within 12 months from Screening Visit

Who the study is looking for

  • Male or female subjects ≥ 18 years of age and \< 76 years of age
  • Diagnosed with diabetes (Type 1 or 2) with hemoglobin A1c ≤ 12.0%
  • Study eye must have NCIDME (Part 1) or CIDME (Part 2)
  • Study eye must be moderate to severe NPDR

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MedTrials, Inc.
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.